Research progress in population pharmacokinetics of rituximab

Author: Mengxue LI ¹ ; Jie HE ¹ ; Xiaxia YU ¹ ; Linlin HU ¹ ; Hua SHAO ¹ ; Linlin HU ²
Author Information

1. Department of Pharmacy, Zhongda Hospital, Southeast University
2. Office of Clinical Trial Institution, Zhongda Hospital, Southeast University
Publication Type:Journal Article
Keywords: individualized therapy; population pharmacokinetics; rituximab
From: Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(4):468-474
CountryChina
Language:Chinese
Abstract: Rituximab, a chimeric human-mouse monoclonal antibody, has been used as a first-line treatment for CD20